home / stock / drio / drio articles
Dario selected to provide integrated approach to improve employee cardiometabolic health - including support for those taking a GLP-1 medication - ...
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, wil...
Demand for Dario's integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization ...
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholder...
Agreement names Dario as the preferred digital health provider for employer clients NEW YORK, Oct. 5, 2023 /PRNewswire/ -- DarioHealth Corp. (NASD...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced a new contract with a national employer to provide its cardiometabolic solution with integrated support for GLP-1s to employees beginning in the third quarter of 2024. “The challenges associated with...
Dario Expands GLP-1 Solution Client Base with New Employer Contract PR Newswire Dario's leading behavior change solutions continue to win interest in the employer, payer and pharmaceutical markets NEW YORK , July 16, 2024 /PRNewswire/ -- DarioHealth Corp....
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, today announced two new studies presented this past weekend at the 84th Annual American Diabetes Association (“ADA”) Scientific Sessions in Orlando. According to the announcement, the first study provides an ...